Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cannabidiol
Compound isolated from Cannabis sativa extract.
Year introduced: 1991(1975)
cannabidiol-3-monomethyl ether [Supplementary Concept]
RN given refers to (1R-trans)-isomer
Date introduced: November 20, 1986
cannabidiol hydroxyquinone [Supplementary Concept]
structure given in first source; an air oxidation product of cannabidiol; inhibits the hepatic microsomal drug-metabolizing enzymes of mice through the decrease of cytochrome P-450 content; RN given refers to (1R-trans)-isomer
Date introduced: April 22, 1992
cannabidiol dimethyl ether [Supplementary Concept]
metabolite of cannabidiol; structure given in first source
Date introduced: October 25, 1990
5-(1,1-dimethylheptyl)cannabidiol [Supplementary Concept]
RN given refers to (1R-trans)-isomer; RN for cpd without isomeric designation not available 5/89; structure given in first source
Date introduced: May 31, 1989
cannabidiol-dimethylheptyl [Supplementary Concept]
cannabidiol derivative
Date introduced: July 16, 2020
dimethylheptane-cannabidiol [Supplementary Concept]
cannabidiol analog
Date introduced: December 17, 2019
HUF-101 [Supplementary Concept]
a a fluorinated cannabidiol analog; has antinociceptive effects in mice
Date introduced: June 15, 2018
Cannabinoids
Compounds having the cannabinoid structure. They were originally extracted from Cannabis sativa L. The most pharmacologically active constituents are TETRAHYDROCANNABINOL; CANNABINOL; and CANNABIDIOL.
Year introduced: 1977
nabiximols [Supplementary Concept]
a combination of the above cpds for treatment of multiple sclerosis pain
Date introduced: March 23, 2014
6''-azidohex-2''-yne-cannabidiol [Supplementary Concept]
structure in first source
Date introduced: November 23, 2004
cannabidiol (abn-cbd, (-)-4-(3-3,4-trans-p-menthadien-(1,8)-yl)olivetol) [Supplementary Concept]
a cannabinoid compound; stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1
Date introduced: May 25, 2004
4-(3-3,4-p-menthadien-(1,8)-yl)olivetol [Supplementary Concept]
has vasodilating activity
Date introduced: December 20, 2003
3-pentyl-6,7,7a,8,9,11a-hexahydro-1,7-dihydroxy-7,10-dimethyldibenzo(b,d)oxepin [Supplementary Concept]
metabolite of cannabidiol; structure in first source
Date introduced: March 15, 1996
desoxycannabidiol [Supplementary Concept]
structure given in first source
Date introduced: July 10, 1995
6-oxocannabidiol glucoside [Supplementary Concept]
a major urinary metabolite of cannabidiol in the dog
Date introduced: May 25, 1990
5''-hydroxycannabidiol glucoside [Supplementary Concept]
4''-hydroxycannabidiol glucoside [Supplementary Concept]
a major urniary metabolite of cannabidiol in the dog
Date introduced: May 24, 1990
cannabielsoin [Supplementary Concept]
Date introduced: September 13, 1989
olivetol [Supplementary Concept]
from cannabidiol by pyrolysis; structure
Date introduced: January 1, 1978